Charge Reversal Liposomes for Cancer Nuclear Drug Delivery

Wednesday, November 10, 2010: 9:30 AM
151 A/B Room (Salt Palace Convention Center)
Xinpeng Ma1, Zhuxian Zhou1, Bo Zhang2, Jianbin Tang3, Maohong Fan1, Huadong Tang1, Youqing Shen3, Maciej Radosz2, Edward Van Kirk4 and William Murdoch4, (1)Department of Chemical and Petroleum Engineering, University of Wyoming, Laramie, WY, (2)University of Wyoming, Laramie, WY, (3)Department of Chemical and Biochemical Engineering, Zhejiang University, Hangzhou, China, (4)Department of Animal Science, University of Wyoming, Laramie, WY

Cationic liposomes have fast cellular uptakes but nonspecific cellular uptakes and are toxic, immediately clear out from the blood, accumulate in lung, Herein, we report liposomes that can undergo negative-to-positive charge-reversal triggered by the solid tumor extracellular- or lysosomal (4-5) acidity for nuclear drug delivery. Doxorubicin loaded in the liposomes is more cytotoxic to tumor cells than the free drug. The liposomes have a long blood circulation time and thus are good for in vivo cancer drug delivery.

Extended Abstract: File Not Uploaded
See more of this Session: Nanomedicine and Drug Delivery I
See more of this Group/Topical: Topical F: Nanotechnology in Medicine